The company operates in two distinct segments: manufacturing and trading diamond-studded gold jewelry and developing residential real estate projects in Gujarat.
The company lacks a competitive advantage, evidenced by extremely low and volatile returns on capital (ROCE 0.7%) and a heavy reliance on related-party transactions for revenue and land sourcing. The jewelry business is a commodity-like trading operation, and the real estate segment lacks scale or brand differentiation.
Capital is primarily deployed into inventory and advances to related entities. The track record is poor, with average ROE near zero (0.4%) and significant capital tied up in 'advances for diamond purchases' and 'shop purchases' that do not generate immediate returns.
The investment collapsed as the company's chronic disregard for regulatory compliance and internal controls finally invited a terminal exchange delisting or regulatory freeze. The reported loss of accounting data in FY25 proved to be the tip of an iceberg, masking a total erosion of capital through unrecoverable advances to related parties. Without a functional business model or transparent financial reporting, the entity devolved into a hollow shell, leaving minority shareholders with no recourse as the promoter-controlled entities prioritized their own liquidity over the company's survival.
RichFakir rates Shukra Jewellery Ltd's business quality as poor — 19/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Shukra Jewellery Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Shukra Jewellery Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Shukra Jewellery Ltd's fair value is about ₹1 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →